Form 8-K · Current report
News Corp 8-K, filed Sep 2, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000193
Summary
News Corp bought back 54,641 shares of its Class A common stock for US$1,678,626.16 on September 1, 2026, and has purchased roughly US$455.8 million of Class A and Class B shares to date under its 2025 Repurchase Program, which authorizes up to US$1 billion. The company reported the transactions to the Australian Securities Exchange under its daily buy-back disclosure requirement.
Key points
- News Corp's 2025 Repurchase Program, authorized as of July 15, 2025, allows repurchases of up to an aggregate US$1 billion of its Nasdaq-listed Class A and Class B common stock.
- Cumulative Class A buy-backs total 11,450,886 shares for US$296,211,905.30, with 54,641 shares bought for US$1,678,626.16 on September 1, 2026.
- Prices paid for Class A shares under the program have ranged from US$22.20 to US$31.58.
- Goldman Sachs & Co. LLC is named as broker, and no ASX-listed CDIs will be repurchased under the program.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.